Coronavirus Notebook: EMA OKs More Vaccine Production Plants, WHO Sounds Alert Over Africa

Vaxzevria should not be given to people who have had capillary leak syndrome, the EU regulator says. The G7 leaders have made big pledges on vaccine donations, and international regulatory bodies have issued a guide to shoring up confidence in vaccination.

MODERNA logo on blue background. Covid19 vaccine vial and syringe
The EU has OKd more manufacturing capacity for the Moderna COVID-19 vaccine • Source: Alamy

The European Medicines Agency says that people who have previously had capillary leak syndrome must not be given AstraZeneca PLC/Oxford University’s COVID-19 vaccine, Vaxzevria, and that CLS should be added to the vaccine’s product information as a new side-effect. 

The agency’s drug safety committee (the PRAC) carried out an in-depth review of six cases of CLS in people who...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet